- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/138 - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
Patent holdings for IPC class A61K 31/138
Total number of patents in this class: 1965
10-year publication summary
|
194
|
169
|
161
|
178
|
183
|
250
|
194
|
173
|
140
|
40
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Antecip Bioventures II LLC | 325 |
52 |
| Apnimed, Inc. (Delaware) | 49 |
25 |
| The Regents of the University of California | 19661 |
19 |
| Novartis AG | 11041 |
18 |
| Pharnext | 92 |
18 |
| Ohemo Life Sciences Inc | 23 |
18 |
| Duke University | 3035 |
17 |
| Genentech, Inc. | 3888 |
16 |
| Jina Pharmaceuticals, Inc. | 31 |
16 |
| Saniona A/S | 47 |
16 |
| Emory University | 1606 |
14 |
| The Board of Trustees of the University of Illinois | 2689 |
13 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3090 |
13 |
| Curasen Therapeutics, Inc. | 46 |
12 |
| Actimed Therapeutics Limited | 24 |
11 |
| Atossa Therapeutics, Inc. | 52 |
11 |
| The Procter & Gamble Company | 22010 |
10 |
| Centre National de La Recherche Scientifique | 10165 |
10 |
| Repros Therapeutics Inc. | 38 |
10 |
| Toa Eiyo Ltd. | 29 |
10 |
| Other owners | 1636 |